Fundraising Fox
Replay Therapeutics
5 known investors
Find your way into Replay Therapeutics
Sign up to see every warm intro you have to Replay Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Replay Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.
Founders & leadership
LM
Lachlan MacKinnonCEO and Founder
AW
Adrian WoolfsonFounder
RC
Robert CoffinExecutive Chairman
MC
Maria Castner-MillerGeneral CounselMaria Castner-Miller is General Counsel at Replay Therapeutics, which develops gene therapies for rare genetic diseases. She brings 25 years of experience across biotechnology, cell and gene therapy, diagnostics, and pharmaceutical companies, supporting strategy, operations, and major transactions.
SS
Saurabh SharmaVP & Head of CMC
SQ
Sam QuinnCorporate Controller
Investors · 5
Artis Ventureslisted by Artis VenturesSan Francisco · $50K – $25M
How we know: Artis Ventures's portfolio page · Not right? Tell us
__Twitter.png)
OMX Ventureslisted by OMX VenturesLincolnshire
How we know: OMX Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Axial VCreportedSan Francisco · $100K – $5M
How we know: the VCSheet dataset · Not right? Tell us
Related companies · 3
AskBioAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Splice BioSpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
Companies working in the same space as Replay Therapeutics.
Frequently asked questions
- What does Replay Therapeutics do?
- Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.
- Who founded Replay Therapeutics?
- Replay Therapeutics was founded by Lachlan MacKinnon, Adrian Woolfson.
- Who are Replay Therapeutics's investors?
- Replay Therapeutics's investors include Artis Ventures, Gaingels, OMX Ventures, Solari Capital, Axial VC.